File(s) under permanent embargo
Should I Have Adjuvant Immunotherapy? An Interview Study Among Adults with Resected Stage 3 Melanoma and Their Partners
Version 2 2024-06-06, 05:20
Version 1 2023-05-03, 23:03
journal contribution
posted on 2024-06-06, 05:20 authored by Ann LivingstoneAnn Livingstone, D Milne, K Dempsey, DM Muscat, AM Menzies, K Howard, MR Stockler, RL MortonShould I Have Adjuvant Immunotherapy? An Interview Study Among Adults with Resected Stage 3 Melanoma and Their Partners
History
Journal
PatientVolume
14Pagination
635-647Location
Chester, Eng.Publisher DOI
ISSN
1178-1653eISSN
1178-1661Language
EnglishPublication classification
C1.1 Refereed article in a scholarly journalIssue
5Publisher
Wolters Kluwer HealthUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC